{"database": "lobbying", "table": "lobbying_activities", "rows": [[2957717, "c0067719-0f91-4171-9d00-6f52944610fe", "Q1", "PUBLIC STRATEGIES WASHINGTON, INC.", 32486, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2023, "first_quarter", "MMM", "Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-04-12T12:55:27-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2957717"], "units": {}, "query_ms": 0.5192130047362298, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}